Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Glutathione | 10 | 2019 | 343 | 2.270 |
Why?
|
| Oxidative Stress | 7 | 2019 | 718 | 1.390 |
Why?
|
| Nucleus Accumbens | 5 | 2019 | 417 | 1.320 |
Why?
|
| Cocaine-Related Disorders | 5 | 2018 | 504 | 0.900 |
Why?
|
| Oxidation-Reduction | 9 | 2019 | 567 | 0.870 |
Why?
|
| Cocaine | 4 | 2019 | 555 | 0.860 |
Why?
|
| Substance-Related Disorders | 3 | 2018 | 1242 | 0.850 |
Why?
|
| Signal Transduction | 8 | 2015 | 2689 | 0.780 |
Why?
|
| Proteome | 2 | 2015 | 87 | 0.770 |
Why?
|
| Neuronal Plasticity | 3 | 2017 | 274 | 0.730 |
Why?
|
| Actin Depolymerizing Factors | 1 | 2019 | 16 | 0.680 |
Why?
|
| Actins | 1 | 2019 | 249 | 0.620 |
Why?
|
| Acetylcysteine | 2 | 2018 | 296 | 0.610 |
Why?
|
| Drug-Seeking Behavior | 1 | 2019 | 213 | 0.560 |
Why?
|
| Drug Delivery Systems | 1 | 2018 | 236 | 0.550 |
Why?
|
| Glutamic Acid | 2 | 2011 | 332 | 0.550 |
Why?
|
| Post-Synaptic Density | 1 | 2015 | 7 | 0.510 |
Why?
|
| Dendritic Spines | 1 | 2015 | 76 | 0.480 |
Why?
|
| Central Nervous System Depressants | 1 | 2015 | 182 | 0.440 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 4 | 2012 | 306 | 0.410 |
Why?
|
| Animals | 18 | 2019 | 20881 | 0.410 |
Why?
|
| Mental Disorders | 2 | 2008 | 659 | 0.390 |
Why?
|
| Glutathione Disulfide | 2 | 2012 | 31 | 0.380 |
Why?
|
| Reactive Nitrogen Species | 1 | 2011 | 32 | 0.370 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2011 | 27 | 0.370 |
Why?
|
| Secretogranin II | 1 | 2010 | 2 | 0.350 |
Why?
|
| Cisplatin | 2 | 2012 | 192 | 0.350 |
Why?
|
| Alcoholism | 2 | 2017 | 1109 | 0.350 |
Why?
|
| Tissue Array Analysis | 1 | 2010 | 53 | 0.350 |
Why?
|
| Stress, Physiological | 1 | 2011 | 215 | 0.330 |
Why?
|
| Motor Activity | 2 | 2017 | 621 | 0.330 |
Why?
|
| Neuropeptides | 1 | 2010 | 106 | 0.330 |
Why?
|
| Receptors, Glutamate | 1 | 2008 | 22 | 0.320 |
Why?
|
| Brain | 3 | 2008 | 2176 | 0.320 |
Why?
|
| Proteomics | 2 | 2011 | 246 | 0.320 |
Why?
|
| Ethanol | 1 | 2015 | 893 | 0.320 |
Why?
|
| Reactive Oxygen Species | 4 | 2018 | 499 | 0.280 |
Why?
|
| Rats | 5 | 2019 | 5300 | 0.260 |
Why?
|
| Hippocampus | 1 | 2008 | 471 | 0.240 |
Why?
|
| Anxiety Disorders | 1 | 2006 | 426 | 0.220 |
Why?
|
| Adaptation, Physiological | 2 | 2017 | 189 | 0.220 |
Why?
|
| Stress, Psychological | 1 | 2008 | 824 | 0.190 |
Why?
|
| Self Administration | 2 | 2019 | 419 | 0.170 |
Why?
|
| Mice | 6 | 2015 | 8474 | 0.170 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2019 | 284 | 0.170 |
Why?
|
| Behavior, Animal | 2 | 2019 | 470 | 0.160 |
Why?
|
| Models, Animal | 1 | 2019 | 252 | 0.160 |
Why?
|
| Molecular Sequence Data | 3 | 2011 | 1447 | 0.160 |
Why?
|
| Male | 10 | 2019 | 37321 | 0.150 |
Why?
|
| Receptors, sigma | 1 | 2017 | 6 | 0.150 |
Why?
|
| Conditioning, Operant | 1 | 2019 | 241 | 0.150 |
Why?
|
| Humans | 13 | 2018 | 68618 | 0.150 |
Why?
|
| Nerve Tissue Proteins | 2 | 2017 | 290 | 0.150 |
Why?
|
| Guanidines | 1 | 2017 | 32 | 0.150 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2015 | 139 | 0.140 |
Why?
|
| Dextran Sulfate | 1 | 2017 | 88 | 0.140 |
Why?
|
| Synapses | 2 | 2017 | 222 | 0.140 |
Why?
|
| Methamphetamine | 1 | 2017 | 132 | 0.130 |
Why?
|
| Colitis | 1 | 2017 | 156 | 0.130 |
Why?
|
| Central Nervous System Stimulants | 1 | 2017 | 221 | 0.130 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 1 | 2017 | 201 | 0.130 |
Why?
|
| Blotting, Western | 2 | 2015 | 954 | 0.130 |
Why?
|
| Dopamine | 1 | 2017 | 474 | 0.130 |
Why?
|
| Cues | 1 | 2019 | 654 | 0.130 |
Why?
|
| Sphingosine | 1 | 2017 | 315 | 0.120 |
Why?
|
| Chromatography, Liquid | 1 | 2015 | 120 | 0.120 |
Why?
|
| Cysteine | 2 | 2014 | 112 | 0.120 |
Why?
|
| Deoxycytidine | 1 | 2014 | 83 | 0.120 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 2550 | 0.110 |
Why?
|
| Tissue Distribution | 2 | 2012 | 282 | 0.110 |
Why?
|
| Drug Combinations | 2 | 2012 | 304 | 0.110 |
Why?
|
| Mucositis | 1 | 2012 | 9 | 0.100 |
Why?
|
| Estramustine | 1 | 2012 | 35 | 0.100 |
Why?
|
| Sexual Dysfunction, Physiological | 1 | 2012 | 22 | 0.100 |
Why?
|
| NF-kappa B | 1 | 2014 | 432 | 0.100 |
Why?
|
| alpha 1-Antichymotrypsin | 1 | 2012 | 7 | 0.100 |
Why?
|
| Penis | 1 | 2012 | 25 | 0.100 |
Why?
|
| alpha 1-Antitrypsin | 1 | 2012 | 61 | 0.100 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2015 | 435 | 0.100 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2012 | 120 | 0.100 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2011 | 7 | 0.100 |
Why?
|
| Prefrontal Cortex | 1 | 2017 | 640 | 0.100 |
Why?
|
| Glutathione S-Transferase pi | 1 | 2011 | 53 | 0.100 |
Why?
|
| Amino Acid Sequence | 2 | 2011 | 1083 | 0.100 |
Why?
|
| Estrogens | 1 | 2012 | 173 | 0.090 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 2011 | 50 | 0.090 |
Why?
|
| Pancreatic Neoplasms | 1 | 2014 | 332 | 0.090 |
Why?
|
| Mice, Knockout | 2 | 2012 | 1692 | 0.090 |
Why?
|
| Glutathione Reductase | 1 | 2010 | 17 | 0.090 |
Why?
|
| Neoplasms | 2 | 2012 | 1667 | 0.090 |
Why?
|
| Glutathione Transferase | 1 | 2011 | 166 | 0.090 |
Why?
|
| Seizures | 1 | 2012 | 279 | 0.090 |
Why?
|
| Nonlinear Dynamics | 1 | 2010 | 55 | 0.090 |
Why?
|
| Databases, Protein | 1 | 2010 | 49 | 0.090 |
Why?
|
| Sulfhydryl Compounds | 1 | 2010 | 73 | 0.090 |
Why?
|
| Brain Chemistry | 1 | 2010 | 173 | 0.080 |
Why?
|
| Homeostasis | 1 | 2011 | 291 | 0.080 |
Why?
|
| Nerve Net | 1 | 2011 | 181 | 0.080 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2008 | 59 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 2 | 2017 | 2791 | 0.080 |
Why?
|
| Computational Biology | 1 | 2010 | 190 | 0.080 |
Why?
|
| Biomarkers, Tumor | 1 | 2012 | 508 | 0.080 |
Why?
|
| Protein Array Analysis | 1 | 2008 | 32 | 0.080 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2008 | 128 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2010 | 1040 | 0.070 |
Why?
|
| Proteins | 1 | 2011 | 474 | 0.070 |
Why?
|
| Synaptic Transmission | 1 | 2008 | 236 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2011 | 2083 | 0.070 |
Why?
|
| Isotope Labeling | 1 | 2006 | 30 | 0.070 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2006 | 59 | 0.070 |
Why?
|
| Electrophoresis | 1 | 2006 | 69 | 0.070 |
Why?
|
| Cells, Cultured | 1 | 2011 | 2673 | 0.060 |
Why?
|
| Algorithms | 1 | 2010 | 1196 | 0.060 |
Why?
|
| Vesicular Monoamine Transport Proteins | 1 | 2017 | 9 | 0.040 |
Why?
|
| Tissue Culture Techniques | 1 | 2017 | 62 | 0.040 |
Why?
|
| Dopamine Agents | 1 | 2017 | 56 | 0.040 |
Why?
|
| Chemokine CXCL2 | 1 | 2017 | 13 | 0.040 |
Why?
|
| Chemokine CXCL1 | 1 | 2017 | 21 | 0.040 |
Why?
|
| Macaca fascicularis | 1 | 2017 | 31 | 0.040 |
Why?
|
| A549 Cells | 1 | 2017 | 50 | 0.040 |
Why?
|
| Amphetamine-Related Disorders | 1 | 2017 | 92 | 0.040 |
Why?
|
| Rats, Wistar | 1 | 2017 | 371 | 0.040 |
Why?
|
| Antioxidants | 1 | 2017 | 304 | 0.030 |
Why?
|
| X-Linked Inhibitor of Apoptosis Protein | 1 | 2014 | 17 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 626 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2014 | 294 | 0.030 |
Why?
|
| Estrone | 1 | 2012 | 9 | 0.030 |
Why?
|
| Metabolic Clearance Rate | 1 | 2012 | 48 | 0.030 |
Why?
|
| Penile Erection | 1 | 2012 | 18 | 0.030 |
Why?
|
| Biotransformation | 1 | 2012 | 69 | 0.030 |
Why?
|
| Gastric Mucosa | 1 | 2012 | 77 | 0.030 |
Why?
|
| Immunoprecipitation | 1 | 2012 | 132 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2012 | 179 | 0.020 |
Why?
|
| Biomarkers | 1 | 2017 | 1593 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 2012 | 219 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2012 | 102 | 0.020 |
Why?
|
| Estradiol | 1 | 2012 | 176 | 0.020 |
Why?
|
| Chromatography, Ion Exchange | 1 | 2011 | 73 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2017 | 1293 | 0.020 |
Why?
|
| Subcellular Fractions | 1 | 2011 | 92 | 0.020 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 2011 | 93 | 0.020 |
Why?
|
| Receptors, AMPA | 1 | 2011 | 99 | 0.020 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2011 | 381 | 0.020 |
Why?
|
| Serpins | 1 | 2012 | 205 | 0.020 |
Why?
|
| Nervous System Diseases | 1 | 2011 | 142 | 0.020 |
Why?
|
| Ligands | 1 | 2011 | 317 | 0.020 |
Why?
|
| Adult | 1 | 2008 | 21403 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2014 | 1851 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2012 | 1745 | 0.020 |
Why?
|
| Apoptosis | 1 | 2014 | 1641 | 0.020 |
Why?
|
| Female | 1 | 2012 | 38074 | 0.010 |
Why?
|